Abstract:Objective To monitor the blood concentration of micro emulsion ciclosporin(sandimmun neoral)in renal transplant recipients and compare the clinical value between blood concentration trough level(C0)and peak level(C2).Methods One hundred and twenty-two cadaveric renal transplant recipients were randomly divided into group Ⅰ(n=62)and group Ⅱ(n=60).All patients were treated with micro emulsion ciclosporin,mycophenolate mofetil(MMF)and adrenal cortex hormone.C0 and C2 in two groups were chosen as indices to monitor the blood concentration and adjust dosage.The target levels C2 of Sandimmun neoral in groupⅠ were 1 200-1 400 ng/ml during the first 3 months after transplantation and 900-1 200 ng/ml from 3 to 6 months after transplantation.The target levels C0 of Sandimmun neoral in groupⅡ were 250-350 ng/ml in the first 3 months after transplantation and 200-250 ng/ml from 3 to 6 months after transplantation.The C0 and C2 values of two groups were compared in 3 months after transplantation(4 different time points of week 1,week 2,week 4,week 12 after transplantation).The linear correlation analysis was taken in C0,C2 values and area under the plasma concentration-time curve(AUC)0-12.The C0,C2 values and AUC0-12 were compared in acute rejection(AR)cases and no AR cases.The C0,C2 values of micro emulsion ciclosporin were recorded when the drug's related hepatotoxicity and nephrotoxicity occurred.And the linear correlation analysis was taken in C0,C2 values and AUC0-12.Results All patients were followed up(mean 12.7 months).There was no significant correlation between C0 values and AUC0-12 in 3 months after renal transplantation(r=0.41,P>0.05).And there was significantly positive correlation between C2 values and AUC0-12(r=0.87,P<0.05).The incidence of AR in groupⅡ was higher than that in groupⅠ(28 % vs.7 %,P<0.05).The average values of micro emulsion ciclosporin C0 in AR patients were within the target range.But C2 values and AUC0-12 of AR patients were significantly lower than that of patients without AR(P<0.05-P<0.01).The C0,C2 values and AUC0-12 had no correlation with micro emulsion ciclosporin related hepatotoxicity and nephrotoxicity.Conclusions C0 value is not a good parameter for monitoring the blood concentration of micro emulsion ciclosporin after renal transplantation.There is significant positive correlation between C2 value and AUC0-12.C2 value is more sensitive to predict rejection and immunosuppression after renal transplantation.

Clinical Study of Coefficient of Variation of Cyclosporine Blood Concentration in Renal Transplant Recipients

The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.

Comparison of clinical value in monitoring blood concentration trough level and peak level of micro emulsion ciclosporin for renal transplant recipients

Linear correlation of C0 with C2 of plasma concentrations of cyclosporin A in prediction of early clinical outcomes of recipients after renal transplantation

The Clinical Value of Enzyme-Multiplied Immunoassay Technique Monitoring the Plasma Concentrations of Cyclosporine A after Renal Transplantation.

Assessment of Cyclosporine A Withdrawal in Renal Allograft Transplant Recipients

Cyclosporine microemulsion C2 monitoring in Chinese heart transplant recipients

Cyclosporine A and Tacrolimus Combined with Enteric-Coated Mycophenolate Sodium Influence the Plasma Mycophenolic Acid Concentration - a Randomised Controlled Trial in Chinese Live Related Donor Kidney Transplant Recipients

Clinical Research of Blood CsA C2 Level Monitoring in Renal Allograft Recipients

Relationship between cyclophilin A Mrna expression and acute rejection of human graft kidney

Tacrolimus Intra-Patient Variability Predicts the Prognosis of Transplant Patients

Optimal Sampling Time-Point for Cyclosporin A Concentration Monitoring in Heart Transplant Recipients.

Efficacy of microemulsion and conventional formulations of cyclosporine A on renal function after renal transplantation

Two Different Doses of Cyclosporine for Patients After Renal Transplantation:Clinical Controlled Study

Comparison of immunosuppressive efficacy of cyclosporine A and tacrolimus on peripheral blood mononuclear cells in renal transplant recipients

Preliminary investigation of monitoring whole blood concentration of cyclosporine A in the patients after allogeneic renal transplantation

Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients

Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients

Comparison between C2 and C0 as a monitoring tool for domestic cyclosporin A microemulsion capsule

Population Pharmacokinetics Of Cyclosporine In Clinical Renal Transplant Patients

Application of Immunosuppressant Protocol with Low Concentration of Cyclosporine A in Patients with Renal Transplantation